Ironwood Pharma's total assets for Q3 2025 were $396.06M, an increase of 15.49% from the previous quarter. IRWD total liabilities were $660.22M for the fiscal quarter, a 1.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.